Psychiatry is the branch of medicine that deals with the diagnosis, treatment, and prevention of mental and emotional disorders.
Depression and anxiety affect up to 15 percent of preschoolers — International investigation published in the Journal of Child Psychology and Psychiatry. – Almost 15 percent of preschoolers have atypically high levels of depression and anxiety, revealed by researchers in a new study published in the Journal of Child Psychology and Psychiatry.
Survey Reveals Binge Drinking Among Older Adults – One of the largest surveys of substance use has found a remarkable amount of binge drinking among older Americans, revealed by researchers at Duke University Medical Center in The American Journal of Psychiatry.
Review provides new insights into the causes of anorexia – individuals with anorexia have an imbalance between circuits in the brain that regulate reward and emotion. – New imaging technology provides insight into abnormalities in the brain circuitry of patients with anorexia nervosa (commonly known as anorexia) that may contribute to the puzzling symptoms found in people with the eating disorder.
UCLA scientists present first genetic evidence for why placebos work — Researchers find genetic link to placebo response in depressive disorder. – In people suffering from major depressive disorder, depression or MDD, genes that influence the brain’s reward pathways may modulate the response to placebos, revealed by researchers.
Mayo Clinic researchers find previous exercise helps stroke patients recover faster – A person who has exercised regularly prior to the onset of a stroke appears to recover more quickly, say researchers from Mayo Clinic in Florida, USA, in the Journal of Neurology, Neurosurgery & Psychiatry.
UNSW and the Black Dog Institute will take part in the largest international study of its type to pinpoint the risk factors associated with bipolar disorder. – Around 500 Australians aged 12 to 30 will be recruited to take part in a new study to know causes of bipolar disorder and related risk factors, to be conducted in collaboration with four major research institutions in the United States – Johns Hopkins University in Baltimore and the Universities of Michigan, Indiana and Washington.
Internet-Based Intervention May Improve Insomnia — Participants who received the Internet intervention for insomnia significantly improved their sleep. – The Internet appears to have considerable potential in delivering a structured behavioral program for insomnia. An online insomnia intervention based on established face-to-face cognitive behavioral therapy techniques appears to improve patients’ sleep.
Amino acid may help treat patients with hair-pulling condition – trichotillomania. – The amino acid N-acetylcysteine appears to reduce symptoms of compulsive hair-pulling in patients with a condition known as trichotillomania, revealed by researchers in a new study.
Schizophrenia linked for first time to chromosome region in study led by Stanford scientists — Schizophrenia and bipolar disorder share genetic roots. – Researchers has discovered that nearly a third of the genetic basis of schizophrenia may be attributed to the cumulative actions of thousands of common genetic variants.
Study finds autistics better at problem-solving — University of Montreal and Harvard University research in Human Brain Mapping. – Autistics, children with autism, are up to 40% faster at problem solving than non autistics, according to a new Universit? de Montr?al and Harvard University study published in the journal Human Brain Mapping.
Much touted ‘depression risk gene’ may not add to risk after all — New look at data confirms strong association between depression and stressful life events. – Stressful life events are strongly associated with a person’s risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect.
FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD – U.S. Food and Drug Administration (FDA) issues safety communication about an ongoing review of stimulant medications used in children with ADHD (Attention deficit hyperactivity disorder).
